Cargando…

Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin

Comparative molecular docking and vixualization analysis of the human thrombin with the SARS CoV-2 Spike glycoprotein and the human ACE-2 receptors is of interest. The data shows that residues spanning positions 30-41 in the ACE-2 have interaction with the spike glycoprotein (UniProt ID: Q9BYF1). Re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhanu, Piyush, Kumar, Nisha Hemandhar, Kumar, Shamini Hemandhar, Relekar, Maitrali, Anand, Daniel Alex, Kumar, Jitendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2020
Materias:	Research-Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505244/ https://www.ncbi.nlm.nih.gov/pubmed/32994678 http://dx.doi.org/10.6026/97320630016532

Ejemplares similares

Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis
por: Bhanu1, Piyush, et al.
Publicado: (2023)

Mitochondria-Targeted, Nanoparticle-Based Drug-Delivery Systems: Therapeutics for Mitochondrial Disorders
por: Buchke, Sakshi, et al.
Publicado: (2022)

Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
por: Prévost, Jérémie, et al.
Publicado: (2021)

SARS-CoV-2 Spike Glycoprotein and ACE2 Interaction Reveals Modulation of Viral Entry in Wild and Domestic Animals
por: Praharaj, Manas Ranjan, et al.
Publicado: (2022)

Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2
por: Yadav, Rohitash, et al.
Publicado: (2021)

Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking
por: Yu, Ran, et al.
Publicado: (2022)

Identifying Hotspots in Binding of SARS-CoV-2 Spike Glycoprotein and Human ACE2
por: Mendis, Jenny, et al.
Publicado: (2021)

Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2
por: C., Selvaa Kumar, et al.
Publicado: (2020)

Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2
por: Ojha, Rupal, et al.
Publicado: (2022)

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021)

Protein lifetimes in aged brains reveal a proteostatic adaptation linking physiological aging to neurodegeneration
por: Kluever, Verena, et al.
Publicado: (2022)

Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2
por: Rathod, Shravan B., et al.
Publicado: (2020)

Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor
por: Durmaz, Bengül, et al.
Publicado: (2020)

Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2
por: Singh, Jitender, et al.
Publicado: (2021)

Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach
por: Aljindan, Reem Y., et al.
Publicado: (2021)

Modelling SARS-CoV-2 spike-protein mutation effects on ACE2 binding
por: Thakur, Shivani, et al.
Publicado: (2023)

Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2
por: Shen, Min, et al.
Publicado: (2020)

Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2
por: Priya, Prerna, et al.
Publicado: (2021)

Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets
por: Shanmugarajan, Dhivya, et al.
Publicado: (2020)

A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor
por: Souza, Pedro F.N., et al.
Publicado: (2020)

Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2
por: Golcuk, Mert, et al.
Publicado: (2022)

Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
por: Saxena, Shailendra K., et al.
Publicado: (2020)

Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors
por: Singh, Rahul, et al.
Publicado: (2021)

Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM
por: Xu, Cong, et al.
Publicado: (2021)

Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2
por: Hayashi, Takuma, et al.
Publicado: (2021)

Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2
por: Basu, Anamika, et al.
Publicado: (2020)

Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
por: Rolta, Rajan, et al.
Publicado: (2021)

Evolutionary and Structural Studies of NCoV and SARS CoV-Spike proteins and their association with ACE2 Receptor
por: Kumar, Amit, et al.
Publicado: (2020)

The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies
por: Papageorgiou, Anastassios C., et al.
Publicado: (2020)

Structure/Function Analysis of Truncated Amino-Terminal ACE2 Peptide Analogs That Bind to SARS-CoV-2 Spike Glycoprotein
por: Mackin, Robert T., et al.
Publicado: (2022)

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction
por: Eka Saputri, Meliana, et al.
Publicado: (2022)

Perturbation of ACE2 Structural Ensembles by SARS-CoV-2 Spike Protein Binding
por: Uyar, Arzu, et al.
Publicado: (2021)

Understanding Mutations in Human SARS-CoV-2 Spike Glycoprotein: A Systematic Review & Meta-Analysis
por: Kumar, Reetesh, et al.
Publicado: (2023)

Uncovering cryptic pockets in the SARS-CoV-2 spike glycoprotein
por: Zuzic, Lorena, et al.
Publicado: (2022)

Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid
por: Ahmad, Shaban, et al.
Publicado: (2022)

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
por: Anand, Sai Priya, et al.
Publicado: (2020)

Bromelain inhibits SARS‐CoV‐2 infection via targeting ACE‐2, TMPRSS2, and spike protein
por: Sagar, Satish, et al.
Publicado: (2021)

Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2
por: Mathur, Aanchal, et al.
Publicado: (2021)

Structure-based docking, pharmacokinetic evaluation, and molecular dynamics-guided evaluation of traditional formulation against SARS-CoV-2 spike protein receptor bind domain and ACE2 receptor complex
por: kumar, B. Harish, et al.
Publicado: (2021)

The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV
por: Awasthi, Mayanka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o3itun34jbi012bbasf0j9rfk3